Phase II study to determine the efficacy of bendamustin [bendamustine; Ribomustin] in patients with recurrent small cell bronchial carcinoma after cytostatic polychemotherapy
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bendamustine (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 13 Nov 2005 New trial record.